A Mendelian randomization study of the effects of blood lipids on breast cancer risk

by Christoph Nowak, Johan Ärnlöv
Published 2018-09-01

Atherosclerotic Aortic Calcification-Associated Polymorphism in HDAC9 and Associations with Mortality, Cardiovascular Disease, and Kidney Disease

by Johan Ärnlöv, Douglas F. Dluzen, Christoph Nowak
Published 2020-07-01

Poorly controlled ambulatory blood pressure in outpatients with peripheral arterial disease

by Nina Dahle, Emma Skau, Jerzy Leppert, Johan Ärnlöv, Pär Hedberg
Published 2021-04-01

A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases

by Lars Lind, Johan Sundström, Johan Ärnlöv, Ulf Risérus, Erik Lampa
Published 2021-02-01

Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels.

by Lars Lind, Johan Sundström, Anders Larsson, Erik Lampa, Johan Ärnlöv, Erik Ingelsson
Published 2019-01-01

Strong Associations between Plasma Osteopontin and Several Inflammatory Chemokines, Cytokines, and Growth Factors

by Anders Larsson, Johanna Helmersson-Karlqvist, Lars Lind, Johan Ärnlöv, Tobias Rudholm Feldreich
Published 2021-07-01

The association between BMI and 90-day mortality in patients with and without diabetes seeking care at the emergency department

by Per Wändell, Axel C. Carlsson, Anders Larsson, Olle Melander, Torgny Wessman, Johan Ärnlöv, Toralph Ruge
Published 2021-09-01

Cystatin C predicts long term mortality better than creatinine in a nationwide study of intensive care patients

by Johanna Helmersson-Karlqvist, Miklos Lipcsey, Johan Ärnlöv, Max Bell, Bo Ravn, Alain Dardashti, Anders Larsson
Published 2021-03-01

Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.

by Jonas Hansson, Ramachandran S Vasan, Johan Ärnlöv, Erik Ingelsson, Lars Lind, Anders Larsson, Karl Michaëlsson, Johan Sundström
Published 2011-01-01

Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans

by Bengt Fellström, Johanna Helmersson-Karlqvist, Lars Lind, Inga Soveri, Måns Thulin, Johan Ärnlöv, Kim Kultima, Anders Larsson
Published 2021-03-01

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice

by Jessica Cedervall, Anca Dragomir, Falk Saupe, Yanyu Zhang, Johan Ärnlöv, Erik Larsson, Anna Dimberg, Anders Larsson, Anna-Karin Olsson
Published 2017-08-01

Proteomic Analysis of Longitudinal Changes in Blood Pressure

by Yi-Ting Lin, Tove Fall, Ulf Hammar, Stefan Gustafsson, Erik Ingelsson, Johan Ärnlöv, Lars Lind, Gunnar Engström, Johan Sundström
Published 2019-10-01

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

by Matthijs A. Velders, Fredrik Calais, Nina Dahle, Tove Fall, Emil Hagström, Jerzy Leppert, Christoph Nowak, Åke Tenerz, Johan Ärnlöv, Pär Hedberg
Published 2019-07-01

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study.

by Torbjörn Ivert, Håkan Malmström, Niklas Hammar, Axel C Carlsson, Per E Wändell, Martin J Holzmann, Ingmar Jungner, Johan Ärnlöv, Göran Walldius
Published 2018-01-01

Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes:...

by Axel C. Carlsson, Christoph Nowak, Lars Lind, Carl Johan Östgren, Fredrik H. Nyström, Johan Sundström, Juan Jesus Carrero, Ulf Riserus, Erik Ingelsson, Tove Fall, Johan Ärnlöv
Published 2020-01-01

Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patien...

by Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud
Published 2017-03-01

Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

by Per Winkel, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre
Published 2020-08-01

Endothelial dysfunction and the risk of heart failure in a community‐based study: the Multi‐Ethnic Study of Atherosclerosis

by Johan Ärnlöv, Yingying Sang, Shoshana H. Ballew, Dhananjay Vaidya, Erin D. Michos, David R. Jacobs Jr, Joao Lima, Michael G. Shlipak, Alain G. Bertoni, Josef Coresh, Michael Blaha, Wendy S. Post, Kunihiro Matsushita
Published 2020-12-01

The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population

by Markus Stenemo, Andrea Ganna, Samira Salihovic, Christoph Nowak, Johan Sundström, Vilmantas Giedraitis, Corey D. Broeckling, Jessica E. Prenni, Per Svensson, Patrik K.E. Magnusson, Lars Lind, Erik Ingelsson, Johan Ärnlöv, Tove Fall
Published 2019-08-01

Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study

by Erik Nilsson, Jens Kastrup, Ahmad Sajadieh, Gorm Boje Jensen, Erik Kjøller, Hans Jørn Kolmos, Jonas Wuopio, Christoph Nowak, Anders Larsson, Janus Christian Jakobsen, Per Winkel, Christian Gluud, Kasper K Iversen, Johan Ärnlöv, Axel C. Carlsson
Published 2020-01-01